Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women with a medical indication for an ovarian stimulation therapy for the purposes of an IVF or ICSI.~* First-time ovarian stimulating therapy for an IVF or ICSI.~* Ovarian stimulation therapy exclusively with Ovaleap®.~* GnRH antagonist protocol.~* Body-Mass-Index (BMI) \< 30 kg/m2.~* Duration of menstrual cycle 24 - 35 days.~  * Additional criteria apply, please contact the investigator for more information~Exclusion Criteria:~* Combined application of IVF and ICSI~* Ovarian hyperstimulation with Ovaleap® with a consecutive social freezing.~* Polycystic ovary syndrome (PCOS).~* Endometriosis (AFS (American Fertility Society) grade 3 and 4).~* Uterine myoma (intramural \> 4 cm, submucosal).~* Hydrosalpinx (on one side or both sides).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Ovaleap® (Type: None): Single group prospective treatment cohort

Based on this trial design, predict the completion outcome and termination type (if applicable).